Predict your next investment

co-ps.com

See what CB Insights has to offer

Investments

16

Portfolio Exits

2

Funds

2

About AMT Capital

AMT Capital Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing AMT Capital

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find AMT Capital in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

AMT Capital Investments

16 Investments

AMT Capital has made 16 investments. Their latest investment was in Aduro BioTech as part of their Series A - II on November 11, 2009.

CBI Logo

AMT Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/13/2009

Series A - II

Aduro BioTech

$2M

Yes

Morningside Technology Ventures, National Institute of Allergy and Infectious Diseases, and U.S. Department of Defense

4/13/2009

Series E

Ormet Circuits

$0.48M

No

2/21/2008

Series D

Ormet Circuits

$0.94M

No

5/9/2005

Series C

Subscribe to see more

$99M

Subscribe to see more

10

12/5/2003

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/13/2009

4/13/2009

2/21/2008

5/9/2005

12/5/2003

Round

Series A - II

Series E

Series D

Series C

Series C

Company

Aduro BioTech

Ormet Circuits

Ormet Circuits

Subscribe to see more

Subscribe to see more

Amount

$2M

$0.48M

$0.94M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Morningside Technology Ventures, National Institute of Allergy and Infectious Diseases, and U.S. Department of Defense

Sources

10

10

AMT Capital Portfolio Exits

2 Portfolio Exits

AMT Capital has 2 portfolio exits. Their latest portfolio exit was Aduro BioTech on April 15, 2015.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/15/2015

IPO

$991

4

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

4/15/2015

00/00/0000

Exit

IPO

Subscribe to see more

Companies

Subscribe to see more

Valuation

$991

Acquirer

Subscribe to see more

Sources

4

10

AMT Capital Fund History

2 Fund Histories

AMT Capital has 2 funds, including Advanced Material Technologies LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/31/1989

Advanced Material Technologies LP

Late-Stage Venture Capital

$18M

1

Advanced Material Technologies II Ltd.

Subscribe to see more

$99M

10

Closing Date

12/31/1989

Fund

Advanced Material Technologies LP

Advanced Material Technologies II Ltd.

Fund Type

Late-Stage Venture Capital

Subscribe to see more

Status

Amount

$18M

$99M

Sources

1

10

AMT Capital Team

3 Team Members

AMT Capital has 3 team members, including current President, Tom H Delimitros.

Name

Work History

Title

Status

Tom H Delimitros

President

Current

Peter A Rivelli

General Partner

Current

Alain Oberrotman

Owner

Current

Name

Tom H Delimitros

Peter A Rivelli

Alain Oberrotman

Work History

Title

President

General Partner

Owner

Status

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.